94271 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms; Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
Process of making crystalline type II aripiprazole
#302Modulators of ATP-binding cassette transporters
#303Quinoxalinones as antibacterial composition
#304SELECTIVE INHIBITORS OF AKT AND METHODS OF USING SAME
#305DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR
#306Quinolinone derivatives as PARP and TANK inhibitors
#307CARBOXYLIC ACID DERIVATIVES
#308Quinolines and their therapeutic use
#309QUINOLINE DERIVATIVES AS CRTH2 RECEPTOR LIGANDS
#310Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#311Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
#312PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE
#313Process for preparing isomers of carmoterol
#314FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL MODULATORS
#315Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
#3162,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USES AS VLA-4 INHIBITORS
#317Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#318DERIVATIVES OF HETEROARYL-ALKYLCARBAMATES, METHODS FOR THEIR PREPARATION AND USE THEREOF AS FATTY ACID AMIDO HYDROLASE ENZYME INHIBITORS
#319Bicyclic androgen and progesterone receptor modulator compounds and methods
#320ANTIBACTERIAL QUINOLINE DERIVATIVES
#321Antibacterial quinoline derivatives
#322ANTIBACTERIAL QUINOLINE DERIVATIVES
#323Method of treating insulin resistance with a selective inhibitor of CB2 receptor activity
#324Substituted arylalkanoic acid derivatives and use thereof
#325Quinoline derivatives as antibacterial agents
#326Beta-2-adrenoreceptor agonists
#327Antibacterial quinoline derivatives
#3284-(1-amino-ethyl)-cyclohexylamine derivatives
#329Fumarate salt of (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
#330Modulators of ATP-binding cassette transporters
#331CRYSTAL FORM OF 8-HYDROXY-5-[(1R)-1-HYDROXY-2-[[(1R)-2-(4-METHOXYPHENYL)-1-METHYLETHYL]AMINO]ETHYL]-2(1H)-QUINOLINONE MONOHYDROCHLORIDE
#332VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS
#333NMDA receptor antagonists for neuroprotection
#334NOVEL COMPOUNDS
#3352-aminobenzamide derivatives
#336Modulators of ATP-binding cassette transporters
#337Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
#338Novel salt form of a Beta2-adrenergic agonist quinolin-2-one derivative
#339Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#340Intermediates useful for the preparation of aripiprazole and methods for the preparation of the novel intermediates and aripiprazole
#341Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts
#342SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR
#343Methods of preparing aripiprazole crystalline forms
#344Quinolines and their therapeutic use
#345Caspase inhibitors and uses thereof
#346NOVEL 2-QUINOLONE DERIVATIVE
#347Aripiprazole Salts
#348Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
#349Therapeutic amides
#350Substituted arylalkanoic acid derivatives and use thereof
#351Substituted biaryl compounds as factor XIa inhibitors
#352Ophthalmic Compositions for Treating Ocular Hypertension
#353ARIPIPRAZOLE CO-CRYSTALS
#354Inhibitors of Fatty Acid Synthase (Fas)
#355Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
#356Novel substituted heteroaryloxy alkylamines and their use as monoamine neurotransmitter re-uptake inhibitors
#357METHOD FOR TREATING ADAMTS-5-ASSOCIATED DISEASE
#358Salts of aripiprazole
#359Phenylalanine derivatives
#360Apoptosis inhibitors
#361Benzonitryl and nitrobenzyl derivatives that modulate androgen receptors
#362Quinoline derivatives as antibacterial agents
#363Inhibitors of human immunodeficiency virus replication
#364Quinoline derivatives as antibacterial agents
#365Process for preparing (alpha S, beta R)-6-bromo-alpha-[2-(dimethylamino) ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
#366ARIPIPRAZOLE CRYSTALLINE FORMS
#367NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#368Antibacterial quinoline derivatives
#369Compounds, Compositions, and Methods
#370Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof
#371MULTIPLY-SUBSTITUTED TETRAHYDRONAPHTHALENE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
#372Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
#373QUINOLONES USEFUL AS INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS
#374Polymorphic forms of aripiprazole and method
#375Cinnamate Salts Of A Beta-2 Adrenergic Agonist
#3763, 4-dihydro-2(IH)-quinolinone and 2(1H)-quinolinone derivatives
#377NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#378NOVEL CRYSTALLINE FORMS OF ARIPIPRAZOLE
#379Modulators of ATP-binding cassette transporters
#3802,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
#381Viral polymerase inhibitors
#382Diamine Beta2 Adrenergic Receptor Agonists
#383N-Acylated lipophilic amino acid derivatives
#384Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
#385Diastereoselective addition of lithiated N-methylimidazole on sulfinimines
#386Certain substituted quinolones, compositions, and uses thereof
#387Fungicide
#388Bicyclic compounds and compositions as PDF inhibitors
#389Process for preparing rebamipide
#390Dipeptidyl peptidase inhibitors
#391Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
#392Antitumor agents
#393Aryl aniline βadrenergic receptor agonists
#394Biaryl sulfonamides and methods for using same
#395Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics
#396Process for the manufacture of aripiprazole by using purified carbostyril compounds such as 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
#397Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#398Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#399Substituted arylalkanoic acid derivatives and use thereof
#400Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#401Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#402Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#403Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#404Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
#405Therapeutic amide derivatives
#406Methods of preparing anhydrous aripiprazole form II
#407Amine salt of carbostyril derivative
#408Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
#409Quinolone derivatives
#410Mycobacterial inhibitors
#411Keratinocyte growth factor receptor—tyrosine specific inhibitors for the prevention of cancer metastatis
#412Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
#413Quinoline potassium channel inhibitors
#4146-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors
#415Quinoline-2-one derivatives for the treatment of airways diseases
#416Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
#417Substituted indoles and a process for preparing substituted indoles
#418Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors
#419Therapeutic amides
#420Method for production $g(a),$g(b)-unsaturated amide compounds
#421Quinoline derivatives as antibacterial agents
#422Method of modulating stress-activated protein kinase system
#423Zeolite composite, method for making and catalytic application thereof
#424Fluorescent chemical compounds having high selectivity for double stranded DNA, and methods for their use
#425Process for the preparation of aripiprazole
#426Process of making crystalline Type II aripiprazole
#427Pharmaceutical tablets of crystalline type II aripiprazole
#428Crystalline aripiprazole salts and processes for preparation and purification thereof
#429Compounds
#430Preventives/remedies for urinary disturbance
#431Phenethanolamine derivative for the treatment of respiratory diseases
#432Compounds
#433Aryl aniline β2 adrenergic receptor agonists
#434Histamine h3 receptor antagonists, preparation and therapeutic uses
#435Benzamides as ppar modulators
#436Ureas as factor Xa inhibitors
#437Substituted biaryl compounds as factor XIa inhibitors
#4384-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
#439Process of making crystalline aripiprazole
#440Crystalline aripiprazole solvates
#441Amide derivatives
#442Zeolite composite, method for making and catalytic application thereof
#443Substantially pure cilostazol and processes for making same
#444Substantially pure cilostazol and processes for making same
#445Methods for identifying and using MarR family polypeptide binding compounds
#446Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
#447Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof
#448Processes for preparing 7-hydroxy-3,4-dihydro-2(1H)-quinolinone and the use in aripiprazole preparation thereof
#449Processes for preparing and purifying carbostyril compounds such as aripiprazole and 7-(4-halobutoxy)-3,4-dihydro-2(1H)-quinolinones
#4502-amino-quinazoline derivatives useful as inhibitors of β-secretase (BACE)
#451Modulators of ATP-binding cassette transporters
#452Sulfonamide bicyclic compounds
#453Preventives/remedies for urinary disturbance
#454Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#455Vanilloid receptor ligands and their use in treatments
#456Method for treating ADAMTS-5-associated disease
#457Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#458Bicyclic androgen and progesterone receptor modulator compounds and methods
#459Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#460Process for preparing aripirazole hydrate
#461Vanilloid receptor ligands and their use in treatments
#462Beta agonists for the treatment of respiratory diseases
#463Vanilloid receptor ligands and their use in treatments
#464Vanilloid receptor ligands and their use in treatments
#465Vanilloid receptor ligands and their use in treatments
#466Diamine βadrenergic receptor agonists
#467Process of making aripiprazole particles
#468Vanilloid receptor ligands and their use in treatments
#469Quinolinone derivatives and uses thereof
#470Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
#471Aripiprazole crystalline forms
#472Vanilloid receptor ligands and their use in treatments
#473Multiply-substituted tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#474Hydroaminomethylation of olefins
#475Process for preparing aripiprazole
#476Method of making 7-(4-bromobutoxy)-3,4-dihydrocarbostyril
#477Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
#478Metabotropic glutamate receptor antagonists
#479Methods of preparing aripiprazole crystalline forms
#480Preventives/remedies for urinary disturbance
#481Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#482Bicyclic compounds and compositions as PDF inhibitors
#483Aryl aniline βadrenergic receptor agonists
#484Histamine-3 receptor modulators
#485Substituted4-aryl-3-(3-aryl-1-oxo-2-propenyl)-2(1h)-quinolinones and analogs as activators of caspases and inducers of apoptosis and the use thereof
#486Antitumor agents
#487Crystalline forms of aripiprazole
#488β2-adrenoceptor agonists
#489Process for making sterile aripiprazole of desired mean particle size
#490Disubstituted chalcone oximes as selective agonists of RAR retinoid receptors
#491Mycobacterial inhibitors
#492Benzyl sulfonamide derivatives
#493Biaryl sulfonamides and methods for using same
#494Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses
#495Benzyl urea and thiourea derivatives
#4962-(Quinolonyl)-fused heterocycles as androgen receptor modulators
#497Androgen receptor antagonists
#498Androgen receptor antagonists
#499Substantially pure cilostazol and processing for making same
#500N-acylated lipophilic amino acid derivatives
#501Quinolinone derivatives as inhibitors of c-fms kinase
#502Piperazine derivatives
#5032-Aminoquinoline compounds
#5043-substituted quinolin-2-one compounds as antibacterial agents